Literature DB >> 9520517

Antagonizing excitotoxicity: a therapeutic strategy for stroke?

D Choi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9520517

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN： 0027-2507


× No keyword cloud information.
  11 in total

Review 1.  Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging.

Authors:  L P Mark; R W Prost; J L Ulmer; M M Smith; D L Daniels; J M Strottmann; W D Brown; L Hacein-Bey
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

Review 2.  P2 receptors and neuronal injury.

Authors:  Heike Franke; Ute Krügel; Peter Illes
Journal:  Pflugers Arch       Date:  2006-04-28       Impact factor: 3.657

3.  Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia.

Authors:  J Ma; J Qiu; L Hirt; T Dalkara; M A Moskowitz
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

4.  Purine receptors are required for DHA-mediated neuroprotection against oxygen and glucose deprivation in hippocampal slices.

Authors:  Simone Molz; Gislaine Olescowicz; Jessica Rossana Kraus; Fabiana Kalyne Ludka; Carla I Tasca
Journal:  Purinergic Signal       Date:  2014-12-14       Impact factor: 3.765

5.  The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia.

Authors:  Candice E Junge; Taku Sugawara; Guido Mannaioni; Sudar Alagarsamy; P Jeffrey Conn; Daniel J Brat; Pak H Chan; Stephen F Traynelis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

6.  pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH.

Authors:  Haichen Wang; Michael L James; Talaignair N Venkatraman; Lawrence J Wilson; Polina Lyuboslavsky; Scott J Myers; Christopher D Lascola; Daniel T Laskowitz
Journal:  Neurocrit Care       Date:  2014-02       Impact factor: 3.210

7.  Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.

Authors:  Bihua Feng; Heong W Tse; Donald A Skifter; Richard Morley; David E Jane; Daniel T Monaghan
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

8.  N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse.

Authors:  Blaise Mathias Costa; Bihua Feng; Timur S Tsintsadze; Richard M Morley; Mark W Irvine; Vera Tsintsadze; Natasha A Lozovaya; David E Jane; Daniel T Monaghan
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

9.  SOD activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure-activity study.

Authors:  Sameh Saad Ali; Joshua I Hardt; Laura L Dugan
Journal:  Nanomedicine       Date:  2008-07-24       Impact factor: 5.307

10.  Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase.

Authors:  Nobuyuki Kuramoto; Megan E Wilkins; Benjamin P Fairfax; Raquel Revilla-Sanchez; Miho Terunuma; Keisuke Tamaki; Mika Iemata; Noel Warren; Andrés Couve; Andrew Calver; Zsolt Horvath; Katie Freeman; David Carling; Lan Huang; Cathleen Gonzales; Edward Cooper; Trevor G Smart; Menelas N Pangalos; Stephen J Moss
Journal:  Neuron       Date:  2007-01-18       Impact factor: 17.173
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.